EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Synthetic Gene Circuits for Regulation of Next‐Generation Cell‐Based Therapeutics

Ana P Teixeira, Martin Fussenegger iD

Advanced Science · 2024-02 · 11 (8)

DOI: 10.1002/advs.202309088 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 21.12.2023. Verfasst von Ana P Teixeira und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosystems Science and Engineering, ETH Zurich, Klingelbergstrasse 48, Basel, CH-4056, Switzerland. Hauptthemen laut MEDLINE: Genes, Synthetic, Gene Regulatory Networks. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council advanced grant, Eidgenössische Technische Hochschule Zürich, Innosuisse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arming human cells with synthetic gene circuits enables to expand their capacity to execute superior sensing and response actions, offering tremendous potential for innovative cellular therapeutics. This can be achieved by assembling components from an ever‐expanding molecular toolkit, incorporating switches based on transcriptional, translational, or post‐translational control mechanisms. This review provides examples from the three classes of switches, and discusses their advantages and limitations to regulate the activity of therapeutic cells in vivo. Genetic switches designed to recognize internal disease‐associated signals often encode intricate actuation programs that orchestrate a reduction in the sensed signal, establishing a closed‐loop architecture. Conversely, switches engineered to detect external molecular or physical cues operate in an open‐loop fashion, switching on or off upon signal exposure. The integration of such synthetic gene circuits into the next generation of chimeric antigen receptor T‐cells is already enabling precise calibration of immune responses in terms of magnitude and timing, thereby improving the potency and safety of therapeutic cells. Furthermore, pre‐clinical engineered cells targeting other chronic diseases are gathering increasing attention, and this review discusses the path forward for achieving clinical success. With synthetic biology at the forefront, cellular therapeutics holds great promise for groundbreaking treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genes, SyntheticGene Regulatory NetworksHumans

Stichwörter der Autor:innen

cell-based therapiesgene controlgene switchesgene therapysynthetic biology

Autor:innen und Institutionen

  • Department of Biosystems Science and Engineering, ETH Zurich, Klingelbergstrasse 48, Basel, CH-4056, Switzerland.
  • Faculty of Science, University of Basel, Klingelbergstrasse 48, Basel, CH-4056, Switzerland.

ORCID-Profile: Martin Fussenegger

Förderung

  • European Research Council advanced grant
  • Eidgenössische Technische Hochschule Zürich
  • Innosuisse
  • Innosuisse - Schweizerische Agentur für Innovationsförderung

Zitieren

APA

Teixeira, A. P., & Fussenegger, M. (2024). Synthetic Gene Circuits for Regulation of Next‐Generation Cell‐Based Therapeutics. Advanced Science, 11(8). https://doi.org/10.1002/advs.202309088

Vancouver

Teixeira AP, Fussenegger M. Synthetic Gene Circuits for Regulation of Next‐Generation Cell‐Based Therapeutics. Advanced Science. 2024;11(8). doi:10.1002/advs.202309088

BibTeX
@article{Teixeira2024,
  author = {Teixeira, Ana P and Fussenegger, Martin},
  title = {Synthetic Gene Circuits for Regulation of Next‐Generation Cell‐Based Therapeutics},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {8},
  doi = {10.1002/advs.202309088}
}
Kostenlos starten →